Introduction
============

Exercise intolerance with dyspnea is a major complaint of patients with advanced COPD.[@b1-copd-12-1061]--[@b4-copd-12-1061] It has been clearly demonstrated that pulmonary rehabilitation (PR), as an essential non-pharmacologic treatment option for COPD, increases exercise tolerance and reduces dyspnea.[@b1-copd-12-1061]--[@b4-copd-12-1061] However, the responses to PR vary significantly and may be unique.[@b1-copd-12-1061]--[@b5-copd-12-1061] It has been reported that some COPD patients receive little or no benefit at all from PR, although the definition of non-responders to PR needs to be considered.[@b1-copd-12-1061]--[@b5-copd-12-1061] In addition, it has been reported that, regardless of whether exercise tolerance was improved in COPD patients on PR, their dyspnea was reduced or their endurance time was prolonged.[@b1-copd-12-1061],[@b6-copd-12-1061]--[@b8-copd-12-1061] In other words, a high exercise tolerance might not be necessary to exercise for a long time. How to identify the possible mechanisms or predictors related to the response to PR is of great interest in the care of COPD patients, and it has not yet been clearly elucidated.

Given that physical exercise requires gas exchange involving the interaction of the ventilatory, cardiovascular, and muscle systems, two parameters (peak oxygen uptake $\left\lbrack {\overset{˙}{V}O}_{2} \right\rbrack$ and exercise time to exhaustion \[T~ex~\]) might characterize total exercise ability.[@b9-copd-12-1061] Evaluating physical exercise might depend on the peak ${\overset{˙}{V}O}_{2}–T_{\text{ex}}$ relationship rather than the peak ${\overset{˙}{V}O}_{2}$ or T~ex~ alone, because it has been reported that, to reach a certain ${\overset{˙}{V}O}_{2}$ during exercise, COPD patients had a longer time than normal subjects, that is, COPD patients could not increase ${\overset{˙}{V}O}_{2}$ steeply.[@b10-copd-12-1061],[@b11-copd-12-1061] Furthermore, keeping in mind that exercise for a long time with the economized ${\overset{˙}{V}O}_{2}$ requirement might be efficient exercise, it was hypothesized that careful consideration of the peak ${\overset{˙}{V}O}_{2}–T_{\text{ex}}$ relationship might be useful for providing detailed evaluations of PR or predicting the degree of response to PR in COPD patients. The T~ex~ equivalent for increased ${\overset{˙}{V}O}_{2}$ was designed to assess the effectiveness of PR. [Figure 1](#f1-copd-12-1061){ref-type="fig"} shows the T~ex~ standardized by the increase of ${\overset{˙}{V}O}_{2}$ from resting to peak exercise during cardiopulmonary exercise testing (CPET), that is, $T_{\text{ex}}/\Delta{\overset{˙}{V}O}_{2}$ (time--slope). As a first purpose of this study, the mechanism by which the responses to PR vary greatly in COPD patients, especially how exercise time but not exercise tolerance improves after PR, was investigated, classifying eligible patients into four groups by whether the T~ex~ or the peak ${\overset{˙}{V}O}_{2}$ was increased after PR: two factors increased (both the T~ex~ and the peak ${\overset{˙}{V}O}_{2}$ increased); two factors decreased; time only increased (the T~ex~ increased but the peak ${\overset{˙}{V}O}_{2}$ economized); and ${\overset{˙}{V}O}_{2}$ only increased (the T~ex~ decreased but the peak ${\overset{˙}{V}O}_{2}$ increased), as shown in [Figure 2](#f2-copd-12-1061){ref-type="fig"}. Second, whether baseline parameters including the time--slope would be good predictors of the response to PR in COPD patients were investigated.

Methods
=======

Subjects
--------

All 121 COPD patients who underwent the PR program for the first time were recruited for the study, and they were evaluated both before and after PR in the National Hospital Organization, Toneyama National Hospital (Japan), between January 2000 and March 2016. A total of 36 patients who were evaluated by CPET with the same protocol (for more detail, refer to the "CPET" section) were retrospectively analyzed. [Figure 3](#f3-copd-12-1061){ref-type="fig"} shows the study design as a flow diagram. The primary diagnosis of COPD was confirmed using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) definition and classification.[@b12-copd-12-1061] Patients were excluded from this study if they had a diagnosis of 1) bronchial asthma, 2) active infection, 3) severe heart disease, or 4) a history of lung resection. Moreover, COPD patients were excluded if there were changes in the drug regimen within 4 weeks before PR, if new treatment was added during PR, or if they were unstable due to other reasons. All patients gave comprehensively their written, informed consent for the procedures of PR and CPET. The study protocol complied with the Declaration of Helsinki. The institutional review board of the NHO's Toneyama National Hospital approved this study (approval number: 1604).

Pulmonary function tests
------------------------

Pulmonary function tests were performed within 1 week before and after PR, as previously described.[@b13-copd-12-1061]

PR
--

PR consisted of four components on an inpatient basis as previously described:[@b14-copd-12-1061] 1) education and instruction; 2) physical therapy; 3) exercise training; and 4) occupational therapy. Exercise training was conducted in three sets daily, every weekday for 4 weeks (20 days) at high-intensity targets with electromechanically braked cycle ergometers. The initial exercise level of each set was set for 6 min at the work rate corresponding to 60% of the peak ${\overset{˙}{V}O}_{2}$ obtained on the baseline CPET. As tolerated by the patient, the exercise duration was first increased to 10 min. Second, the training work rate was increased by 5 W and then extended to the work rate corresponding to 80% of the baseline peak ${\overset{˙}{V}O}_{2}$. If the patient found the set intolerable, it was reduced to its previous setting.

CPET
----

Symptom-limited incremental exercise tests were performed using an electrically braked cycle ergometer (CV-1000SS; Lode, Groningen, the Netherlands) and a CPET system (Vmaxs-29C; CareFusion 207, Palm Springs, CA, USA) before and after PR with a similar protocol, that is, 2-min increments to 10 W and the same air conditions. Before CPET, patients were asked to make their maximal efforts. To achieve reliable data, CPET was performed until subject exhaustion without encouragement, especially during exercise. All patients were asked to maintain a speed of \~60 rpm on the cycle ergometer, looking at the rpm meter. Pre-exercise resting measurements were taken during the steady-state period after at least 3 min of breathing using a mask. Ventilatory values were measured on a breath-by-breath basis and are presented as 30-s averages at rest, during exercise at 2-min intervals, and at the end of exercise. Intensities of dyspnea (Borg scale) were assessed at rest, during the last 15 s of each exercise stage, and at the end of exercise. At the baseline CPET evaluation of all patients, arterial blood was collected at rest, during the last 15 s of each exercise stage, and at the end of exercise. Arterial blood samples for blood gas analyses and plasma lactate were taken as previously described.[@b13-copd-12-1061] Immediately after exercise, all patients were asked in a non-leading fashion about which symptoms (exertional dyspnea, leg discomfort, or others) caused them to stop the exercise.

Data analysis and statistical analysis
--------------------------------------

The anaerobic threshold (AT) was determined for each patient from a plot of ${\overset{˙}{V}\text{CO}}_{2}$ and ${\overset{˙}{V}O}_{2}$ during exercise (the V-slope technique), which was obtained by the agreement of two independent investigators. Iso-time was defined as the highest equivalent exercise time achieved during CPETs performed before and after PR. The time--slope was determined as the ratio of T~ex~ standardized by $\Delta{\overset{˙}{V}O}_{2}$ (peak minus resting ${\overset{˙}{V}O}_{2}$) during CPET (T~ex~/ $\Delta{\overset{˙}{V}O}_{2}$). Classifying all patients into four groups by whether the T~ex~ or the peak ${\overset{˙}{V}O}_{2}$ was increased after PR, the relationship was investigated between the post-to-pre-change ratio of T~ex~ and the post-to-pre-change ratio of peak ${\overset{˙}{V}O}_{2}$ ([Figure 2](#f2-copd-12-1061){ref-type="fig"}). To compare the baseline characteristics before PR between the two factors increased group (both the T~ex~ and the peak ${\overset{˙}{V}O}_{2}$ increased) and the time only increased group (the T~ex~ increased, but the peak ${\overset{˙}{V}O}_{2}$ economized), Fisher's exact tests and Wilcoxon rank-sum tests were used. The distribution of reasons for stopping exercise was assessed using Fisher's exact *t*-tests. The results after PR were compared with the pre-PR results within each group using paired *t*-tests, and the mean differences in outcome parameters between the two groups were analyzed using unpaired *t*-tests. To assess the relationships between baseline parameters and the ratio of the time--slope at post-PR to the time--slope at pre-PR, Spearman's rank correlation coefficients were used. Data were expressed as mean ± SD, unless otherwise specified. A *P*\<0.05 was considered significant (SAS 9.1.3; SAS Institute, Inc., Cary, NC, USA).

Results
=======

The characteristics of the 36 patients are shown in [Table 1](#t1-copd-12-1061){ref-type="table"}. Most patients were male (97%) with severe-to-very severe airways obstruction (94%) according to the GOLD stages. All patients were ex-smokers. Home oxygen therapy was required for three patients.

First, the effects of PR on ${\overset{˙}{V}O}_{2}$ and T~ex~ were investigated across all patients. [Figure 2](#f2-copd-12-1061){ref-type="fig"} shows the relationship between the post-to-pre-change ratio of T~ex~ and the post-to-pre-change ratio of peak ${\overset{˙}{V}O}_{2}$. After PR, most patients (80%) increased T~ex~; of note, 18 patients (50%) increased T~ex~ but reduced peak ${\overset{˙}{V}O}_{2}$.

Second, to investigate why PR improved T~ex~, reducing exercise tolerance in COPD patients, the response to PR was compared between the time only increased group (the T~ex~ increased, but the peak ${\overset{˙}{V}O}_{2}$ economized) (n=18) and the two factors increased group (both the T~ex~ and the peak ${\overset{˙}{V}O}_{2}$ increased) (n=11), as shown in [Figure 2](#f2-copd-12-1061){ref-type="fig"}. There was no significant difference in the percentage of total work performed during PR to the target work (the work rate corresponding to 80% of the baseline peak ${\overset{˙}{V}O}_{2}$× total estimated time; time only increased group: 57.0%±28.5% vs two factors increased group: 65.0%±14.3%, *P*=0.429). Before PR, there were no differences in the characteristics and pulmonary functions between the two groups ([Table 2](#t2-copd-12-1061){ref-type="table"}). After PR, the distribution of reasons for stopping exercise was not different between the two groups (time only increased group: dyspnea \[n=7, 39%\], leg discomfort \[n=11, 61%\] vs two factors increased group: dyspnea \[n=5, 45%\], leg discomfort \[n=6, 55%\]). Although there was no significant difference in the resting response of PR between the groups, the mean difference (post-PR minus pre-PR) in the ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$ at rest was increased in the time only increased group (within-group: *P*\<0.05). At peak exercise and iso-time, the mean difference in dyspnea level was improved in each group, but there was no significant difference between the groups ([Tables 3](#t3-copd-12-1061){ref-type="table"} and [4](#t4-copd-12-1061){ref-type="table"}). At peak exercise, the V~D~/V~T~ was relatively low and similar in both groups ([Table 3](#t3-copd-12-1061){ref-type="table"}). Compared with the two factors increased group, in the time only increased group, the mean differences in 1) ${\overset{˙}{V}O}_{2}$ (at peak exercise, *P*\<0.0001; at iso-time, *P*\<0.0001; at AT, *P*=0.0001), ${\overset{˙}{V}\text{CO}}_{2}$ (at peak exercise, *P*\<0.0001; at iso-time, *P*=0.0003; at AT, *P*=0.0003), and ${\overset{˙}{V}}_{E}$ (at peak exercise, *P*=0.004) were lower, 2) ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$ (at peak exercise, *P*=0.034; at iso-time, *P*=0.047) and ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$ (at peak exercise, *P*=0.006; at iso-time, *P*=0.017) were higher, and 3) ΔFO~2~, which was calculated by the inspired gas oxygen concentration (FiO~2~) minus expired gas oxygen concentration (FeO~2~), was lower (at peak exercise, *P*=0.0002; at iso-time, *P*=0.006; [Tables 3](#t3-copd-12-1061){ref-type="table"} and [4](#t4-copd-12-1061){ref-type="table"}; [Figure 4](#f4-copd-12-1061){ref-type="fig"}). After PR, there was no difference in the ratio of observed peak heart rate (HR) to predicted peak HR (220 -- age \[years\]) between the two groups (time only increased group: 81.7% vs the two factors increased group: 84.4%, *P*=0.578).

Third, within all patients, to confirm the clinical predictors of responders who could exercise more efficiently after PR, the relationship between baseline variables and the post-to-pre-change ratio of the time--slope was investigated. A significant negative correlation with the baseline time--slope (*r*=−0.496, *P*=0.002; [Table 5](#t5-copd-12-1061){ref-type="table"}; [Figure 5](#f5-copd-12-1061){ref-type="fig"}) and a positive correlation with body mass index (BMI) (*r*=0.496, *P*=0.002) were obtained ([Table 5](#t5-copd-12-1061){ref-type="table"}).

Discussion
==========

This study shows that 1) in half of the COPD patients in the present study, PR increased T~ex~, but reduced peak ${\overset{˙}{V}O}_{2}$. The effectiveness of PR might lie in improving T~ex~ rather than exercise tolerance. As one of the key mechanisms, both required ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$ were reduced during exercise after PR, resulting in reduced ventilatory requirements without cardiac loads, which in turn might make it possible to exercise more efficiently for a long time with decreasing dyspnea. The exertional improvement was reflected in increases of ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$, and the decreases of V~D~/V~T~ and ΔFO~2~ (the difference between the inspired gas oxygen concentration and expired gas oxygen concentration), and 2) the relationship between baseline variables and the post-to-pre-change ratio of the time--slope was investigated. A significant negative correlation with the baseline time--slope and a positive correlation with the baseline BMI were obtained, which could help predict COPD patients' response to PR.

The most striking evidence is that PR increased T~ex~ with economized ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$ during exercise in half of the present study population, although it has been clearly demonstrated that PR increases exercise tolerance in COPD patients.[@b1-copd-12-1061],[@b3-copd-12-1061],[@b4-copd-12-1061] In the time only increased group, the ${\overset{˙}{V}}_{E}$ was reduced after PR at peak exercise, and both ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$ were also reduced during exercise, resulting in increases of the ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$ ratio and the ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$ ratio. This phenomenon was different from the data that were evaluated by Casaburi et al[@b1-copd-12-1061] using incremental exercise testing in severe COPD. The ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$ ratio and ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$ ratio, both of which have been used to evaluate the degree of disease or the effect of interventions in COPD, have again been investigated with interest.[@b15-copd-12-1061]--[@b18-copd-12-1061] To investigate what is meant by the high ventilatory equivalent ratios obtained during exercise after PR, the factors that contribute to the change in the numerator (the reduced ${\overset{˙}{V}}_{E}$) and the change in the denominator (the reduced ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$) should be considered, taking into account some mechanisms. First, generally, high ventilatory equivalent ratios are obtained when wasted ventilation occurs. In this study, however, a reduced ventilatory requirement was obtained after PR. This phenomenon may be explained by the finding at peak exercise that, although compared with the two factors increased group, the mean difference from pre-PR in V~T~ was lower in the time only increased group (*P*=0.043), the reduced mean difference in breathing frequency was similar in the two groups ([Table 3](#t3-copd-12-1061){ref-type="table"}). Furthermore, of note, despite the high ventilatory equivalent ratios, relatively low V~D~/V~T~ ratios during exercise were obtained after PR in the time only-increased group. The mean difference in the V~D~/V~T~ ratio was similar in the two groups after PR during CPET ([Tables 3](#t3-copd-12-1061){ref-type="table"} and [4](#t4-copd-12-1061){ref-type="table"}). Second, the timing during CPET at which the ventilatory requirement ratios were evaluated should also be confirmed, considering its lowest value (nadir) in the hyperbolic curve. Since Neder et al[@b17-copd-12-1061] reported that the nadir values were reached at peak exercise in all GOLD stage III and IV patients, it might mean that evaluation for ventilatory requirement ratios might be enough at peak exercise in such a group. In this study, however, at peak exercise as well as at iso-time, the higher ventilatory equivalent ratios obtained were similar. In addition, it should be confirmed whether they stopped exercise far before the assumed nadir. In this study, the T~ex~ after PR was prolonged enough in each group, and the level of dyspnea was similar in the two groups; that is, these data do not show that higher ventilatory equivalent ratios were obtained due to too short T~ex~. Third, high ventilatory equivalent ratios were also reported in patients with cardiac disease, which decreases cardiac output.[@b19-copd-12-1061] However, there may be no clinically significant difference in cardiac function between the two groups, since after PR, the peak HR and the ratio of observed peak HR to predicted peak HR were similar in both groups. Fourth, ${\overset{˙}{V}O}_{2}$ is determined by analysis of expired gas, including FiO~2~ and FeO~2~. ΔFO~2~ (FiO~2~ minus FeO~2~) was investigated as an outcome variable in this study. After PR, a significant reduction in ΔFO~2~ was obtained in the time only increased group during exercise ([Tables 3](#t3-copd-12-1061){ref-type="table"} and [4](#t4-copd-12-1061){ref-type="table"}; [Figure 4](#f4-copd-12-1061){ref-type="fig"}). This phenomenon means that, because the level of FiO~2~ is generally constant, the level of FeO~2~ was increased after PR, that is, lesser oxygen could not only be achieved, but it was adequate for exercise in the time only increased group, given that the ventilatory requirements were reduced without significant cardiac loads, as discussed earlier. If so, the reasons why higher ventilatory equivalent ratios were obtained might include a reduced metabolic requirement, for example, by peripheral skeletal muscles, for a given exercise, resulting in the economized ${\overset{˙}{V}O}_{2}$ followed by the resultant economized ${\overset{˙}{V}\text{CO}}_{2}$.

Not only cardioventilatory dysfunction but also muscle dysfunction might explain exercise intolerance as a major consequence of COPD. It has been reported that a shift from type I (slow-twitch) fibers to type II (fast-twitch) fibers occurs commonly in advanced COPD.[@b20-copd-12-1061] It was reported that, after PR, the proportion of type IIb fibers decreased in COPD patients, and the proportion of type I fibers increased, especially in non-cachectic COPD patients.[@b21-copd-12-1061] Of note, using neuromuscular blockade to block type I fibers, Krustrup et al[@b22-copd-12-1061] demonstrated that type II-dominant fibers, which were obtained after blocking type I fibers, required higher muscle ${\overset{˙}{V}O}_{2}$. These reports might help to understand the findings that the ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$ were economized after PR in the time only increased group, if PR could increase the proportion of type I fibers. In addition to the exercise responses, from the resting condition, a higher ventilatory equivalent ratio was confirmed in the time only increased group ([Tables 3](#t3-copd-12-1061){ref-type="table"} and [4](#t4-copd-12-1061){ref-type="table"}; [Figure 4](#f4-copd-12-1061){ref-type="fig"}); that is, there may have been a reduced peripheral oxygen requirement from the resting condition. Furthermore, it was also reported that muscle capillarity, which is related to blood flow and oxygen delivery, was reduced in advanced COPD, and PR increased capillarity.[@b21-copd-12-1061],[@b23-copd-12-1061] Given the above findings, the phenomena in this study might be explained by the theory that an economized peripheral oxygen requirement at a given exercise might probably occur because of the change in a fiber-type profile and/or the peripheral oxygen delivery PR might induce, which in turn might be followed by the resultant economized carbon dioxide elimination. Additional studies are needed to confirm this theory.

Investigating the predictors of the response to PR may be clinically useful. [Figure 2](#f2-copd-12-1061){ref-type="fig"} shows whether exercise tolerance improved and that T~ex~ was prolonged in the present population; both of which seem independent, but they are clinically important outcomes.[@b9-copd-12-1061] In this study, the post-to-pre-change rate of the time--slope was negatively correlated with the baseline time--slope and positively correlated with BMI, which in turn, importantly, was not correlated with baseline T~ex~ or baseline peak ${\overset{˙}{V}O}_{2}$ alone ([Table 5](#t5-copd-12-1061){ref-type="table"}, [Figure 5](#f5-copd-12-1061){ref-type="fig"}). This means that underweight patients who have a high baseline time--slope might gain less benefit from PR based on whether their baseline exercise tolerances or T~ex~ were or were not adequate. It has been reported that the obtained value of peak ${\overset{˙}{V}O}_{2}$ during CPET was almost the same with different exercise loads in severe COPD, that is, the slopes of ${\overset{˙}{V}O}_{2} - T_{\text{ex}}$ were different.[@b24-copd-12-1061],[@b25-copd-12-1061] Therefore, more attention needs to be given to the ratio between T~ex~ and $\Delta{\overset{˙}{V}O}_{2}$ during exercise, and further studies should be conducted using different exercise loads to assess the benefit of PR. Nevertheless, the time--slope would potentially contribute to predicting the degree of the PR response beforehand.

This study had some limitations. First, this study was retrospective, and the number of subjects was small. A large prospective study should be conducted. Second, the duration of PR including exercise training was short. A more effective exercise training program, considering its duration, intensity, and frequency, should be explored in the future. Third, this study was primarily performed in patients with severe-to-very severe airflow limitation. Whether the present findings hold true for the total spectrum of COPD patients, evaluating not only cardioventilatory function but also peripheral oxygen delivery function, as in skeletal muscle, should be investigated and recommended as a future research direction in the field of PR.

Conclusion
==========

As one of the key mechanisms, by which the effect of PR on T~ex~ rather than exercise tolerance was confirmed in half of the COPD patients in this study, both ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}\text{CO}}_{2}$ were economized during exercise after PR, resulting in a reduced ventilatory requirement without cardiac loads, followed by decreasing dyspnea. The exertional improvement was reflected in 1) the increases of ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$ and ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$ and 2) the decreases of V~D~/V~T~ and the difference between the inspired gas oxygen concentration and expired gas oxygen concentration. In addition, the time--slope and BMI would potentially contribute as predictors of the response to PR beforehand. A better understanding of the physiologic benefits of PR will lead to more appropriate treatment that will improve exercise tolerance, as well as quality of life, by increasing physical activity levels.
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![Exercise time (T~ex~)/Δ oxygen uptake $\left( {\overset{˙}{V}O}_{2} \right)$, that is, time--slope.\
**Note:** The T~ex~ standardized by the increase of ${\overset{˙}{V}O}_{2}$ from resting to peak exercise during cardiopulmonary exercise testing.](copd-12-1061Fig1){#f1-copd-12-1061}

![The effects of PR on peak ${\overset{˙}{V}O}_{2}$ and T~ex~.\
**Note:** All patients are classified into four groups by whether the exercise time (T~ex~) or the peak oxygen uptake $\left( {\overset{˙}{V}O}_{2} \right)$ did or did not increase after PR.\
**Abbreviation:** PR, pulmonary rehabilitation.](copd-12-1061Fig2){#f2-copd-12-1061}

![Study flow diagram.\
**Abbreviations:** CPET, cardiopulmonary exercise testing; PR, pulmonary rehabilitation.](copd-12-1061Fig3){#f3-copd-12-1061}

![The changes of exercise variables before and after pulmonary rehabilitation.\
**Notes:** In the time only increased group, the data for peak exercise in 18 patients and the data for AT, which were obtained at both pre- and post-PR, in 12 patients were used. In the two factors increased group, the data for peak exercise in 11 patients and the data for AT, which were obtained at both pre- and post-PR, in 10 patients were used. The post-PR results are compared with the pre-PR results within each group (^\*^*P*\<0.05, ^\*\*^*P*\<0.01, ^\*\*\*^*P*\<0.001, ^\*\*\*\*^*P*\<0.001) and between the two groups (^\#^*P*\<0.05, ^\#\#^*P*\<0.01, ^\#\#\#^*P*\<0.001, ^\#\#\#\#^*P*\<0.001) using paired *t*-tests and unpaired *t*-tests, respectively.\
**Abbreviations:** AT, anaerobic threshold; ΔFO~2~, the inspired oxygen concentration (FiO~2~) minus expired oxygen concentration (FeO~2~); peak ex., peak exercise; ${\overset{˙}{V}\text{CO}}_{2}$, carbon dioxide output; ${\overset{˙}{V}}_{E}$, minute ventilation; ${\overset{˙}{V}O}_{2}$, oxygen uptake.](copd-12-1061Fig4){#f4-copd-12-1061}

![Correlation between the ratio of the post-to-pre-change ratio of the time--slope and the baseline time--slope.\
**Abbreviation:** PR, pulmonary rehabilitation.](copd-12-1061Fig5){#f5-copd-12-1061}

###### 

Baseline patient characteristics (n=36)

  -------------------------------------------------- -------------------------
  Age, years                                         69.0±8.4 (53--83)
  Sex, male/female                                   35/1
  Weight, kg                                         52.5±10.7 (34.7--88.0)
  BMI, kg⋅m^−2^                                      20.2±3.7 (14.7--33.5)
  GOLD stage, I/II/III/IV                            1/1/20/14
  Pulmonary function                                 
   FEV~1~, L                                         0.90±0.37 (0.42--2.34)
   %FEV~1~, % predicted                              34.5±13.9 (15.5--89.7)
   FEV~1~/FVC, %                                     40.6±9.8 (18.7--65.2)
   VC, L                                             2.77±0.61 (1.47--3.98)
   %VC, %                                            87.0±16.8 (45.9--115.9)
  Incremental CPET                                   
   Exercise time, sec                                437±177 (170--776)
   Peak ${\overset{˙}{V}O}_{2}$, mL⋅kg^−1^⋅min^−1^   13.8±3.9 (8.1--22.2)
  Medications                                        
   LAMA                                              12
   SAMA                                              10
   LABA                                              7
   SABA                                              7
   ICS                                               6
   Methylxanthines                                   21
  -------------------------------------------------- -------------------------

**Notes:** Data are presented as mean ± SD (range) unless otherwise stated. Medications are not mutually exclusive, and data are presented separately.

**Abbreviations:** BMI, body mass index; CPET, cardiopulmonary exercise testing; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ICS, inhaled corticosteroids; LABA, long-acting β~2~-agonist; LAMA, long-acting muscarinic antagonist; SABA, short-acting β~2~-agonist; SAMA, short-acting muscarinic antagonist; VC, vital capacity; ${\overset{˙}{V}O}_{2}$, oxygen uptake.

###### 

Patient characteristics of the two groups before pulmonary rehabilitation

                                                 Time only-increased group (n=18)   Two factors-increased group (n=11)   *P*-value between groups
  ---------------------------------------------- ---------------------------------- ------------------------------------ --------------------------
  Age, years                                     69.7±7.9                           71.6±7.7                             0.357
  BMI, kg⋅m^−2^                                  20.6±2.9                           21.0±5.0                             0.964
  GOLD stage, I/II/III/IV                        0/1/12/5                           1/0/6/4                              0.463
  Pulmonary function                                                                                                     
   FEV~1~, L                                     0.93±0.32                          0.94±0.50                            0.406
   %FEV~1~, % predicted                          35.4±11.5                          37.6±19.3                            0.653
   FEV~1~/FVC, %                                 39.7±9.5                           44.8±10.9                            0.291
   VC, L                                         2.83±0.65                          2.70±0.59                            0.445
   %VC, %                                        88.1±17.6                          87.6±17.7                            0.653
  CPET with BGA, at peak exercise                                                                                        
    ${\overset{˙}{V}O}_{2}$, mL⋅min^−1^⋅kg^−1^   14.8±3.7                           14.2±3.4                             0.707
   pH                                            7.351±0.040                        7.344±0.052                          0.702
   PaO~2~, mmHg                                  63.3±13.1                          63.6±11.4                            0.964
   PaCO~2~, mmHg                                 43.7±6.4                           43.2±6.6                             0.857
   Plasma lactate, mg⋅dL^−1^                     34.7±12.4                          35.3±13.6                            0.963

**Notes:** Data are presented as mean ± SD (range) unless otherwise stated. In the time only increased group, exercise time was increased, but the peak ${\overset{˙}{V}O}_{2}$ was economized after pulmonary rehabilitation; in the two factors increased group, both the exercise time and the peak ${\overset{˙}{V}O}_{2}$ were increased after pulmonary rehabilitation.

**Abbreviations:** BGA, blood gas analyses; BMI, body mass index; CPET, cardiopulmonary exercise testing; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; PaCO~2~, arterial carbon dioxide tension; PaO~2~, arterial oxygen tension; VC, vital capacity; ${\overset{˙}{V}O}_{2}$, oxygen uptake.

###### 

Changes in incremental exercise parameters at peak exercise after pulmonary rehabilitation

                                                            Time only-increased group (n=18)   Two factors-increased group (n=11)                              *P*-value between groups                                                               
  --------------------------------------------------------- ---------------------------------- --------------------------------------------------------------- -------------------------- ----------------------------------------------------------- ----------
  Dyspnea, Borg scale                                       6.6±2.2                            −1.3±2.2[\*](#tfn6-copd-12-1061){ref-type="table-fn"}           6.5±2.7                    −1.7±1.8[\*](#tfn6-copd-12-1061){ref-type="table-fn"}       0.663
  ${\overset{˙}{V}O}_{2}$, mL⋅min^−1^                       739±213                            −65±39[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}       730±208                    82±52[\*\*\*](#tfn8-copd-12-1061){ref-type="table-fn"}      \<0.0001
  Exercise time, sec                                        421±173                            72±71[\*\*\*](#tfn8-copd-12-1061){ref-type="table-fn"}          465±171                    124±57[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}   0.050
  Time--slope, sec⋅mL^−1^⋅min                               0.93±0.33                          0.28±0.22[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}    0.94±0.14                  0.07±0.15                                                   0.011
  F, breaths⋅min^−1^                                        30.3±5.8                           −1.2±6.9                                                        30.1±4.5                   −0.9±6.2                                                    0.903
  V~T~, mL                                                  1,072±297                          29±169                                                          1,086±322                  164±160[\*\*](#tfn7-copd-12-1061){ref-type="table-fn"}      0.043
  ${\overset{˙}{V}}_{E}$, L⋅min^−1^                         31.4±7.4                           −0.7±2.8                                                        32.6±11.2                  3.6±4.6[\*](#tfn6-copd-12-1061){ref-type="table-fn"}        0.004
  ${\overset{˙}{V}\text{CO}}_{2}$, mL⋅min^−1^               768±260                            −69±56[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}       773±273                    114±73[\*\*\*](#tfn8-copd-12-1061){ref-type="table-fn"}     \<0.0001
  R                                                         1.03±0.12                          0.00±0.06                                                       1.04±0.10                  0.03±0.05                                                   0.182
  V~D~/V~T~                                                 0.35±0.06                          0.01±0.05                                                       0.35±0.08                  −0.02±0.04                                                  0.137
  ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$           43.4±5.2                           3.6±4.3[\*\*](#tfn7-copd-12-1061){ref-type="table-fn"}          44.8±9.5                   −0.1±4.5                                                    0.034
  ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$   43.0±7.7                           3.5±4.4[\*\*](#tfn7-copd-12-1061){ref-type="table-fn"}          43.0±8.0                   −1.4±4.2                                                    0.006
  ΔFO~2~, %                                                 2.88±0.35                          −0.31±0.25[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}   2.82±0.55                  0.17±0.33                                                   0.0002
  T~i~/T~tot~                                               35.3±7.4                           2.7±5.2[\*](#tfn6-copd-12-1061){ref-type="table-fn"}            38.5±5.6                   0.5±4.0                                                     0.228
  HR, beats⋅min^−1^                                         121.1±19.4                         1.4±17.3                                                        120.3±19.2                 5.5±11.7                                                    0.504
  ${\overset{˙}{V}O}_{2}$/HR, mL⋅beats^−1^                  6.2±1.7                            −0.7±0.4[\*\*\*\*](#tfn9-copd-12-1061){ref-type="table-fn"}     6.0±1.0                    0.4±0.5[\*](#tfn6-copd-12-1061){ref-type="table-fn"}        \<0.0001
  SpO~2~, %                                                 90.2±5.9                           −0.5±3.4                                                        90.6±4.7                   −0.9±3.9                                                    0.779

**Notes:** Data are presented as mean ± SD. The data of 33 patients were obtained from CPET performed under room air conditions, that is, FiO~2~ =21%. The FiO~2~ of two patients was 24%, and the FiO~2~ of one patient was 30%.

*P*\<0.05,

*P*\<0.01,

*P*\<0.001,

*P*\<0.001. The post-PR results were compared with the pre-PR results within each group. In the time only increased group, exercise time was increased, but the peak ${\overset{˙}{V}O}_{2}$ was economized after pulmonary rehabilitation; in the two factors increased group, both the exercise time and the peak ${\overset{˙}{V}O}_{2}$ were increased after pulmonary rehabilitation.

**Abbreviations:** ΔFO~2~, the inspired oxygen concentration (FiO~2~) minus expired oxygen concentration (FeO~2~); F, breathing frequency; HR, heart rate; R, gas exchange ratio; SpO~2~, oxygen saturation; T~i~/T~tot~, the ratio of inspiratory time to total breathing cycle time; time--slope, exercise time/ $\Delta{\overset{˙}{V}O}_{2}$; ${\overset{˙}{V}\text{CO}}_{2}$, carbon dioxide output; V~D~/V~T~, physiologic dead space/tidal volume ratio; ${\overset{˙}{V}}_{E}$, minute ventilation; ${\overset{˙}{V}O}_{2}$, oxygen uptake; V~T~, tidal volume.

###### 

Changes in incremental exercise parameters at iso-time after pulmonary rehabilitation

                                                            Time only-increased group (n=18)   Two factors-increased group (n=11)                             *P*-value between groups                                                                
  --------------------------------------------------------- ---------------------------------- -------------------------------------------------------------- -------------------------- ------------------------------------------------------------ ----------
  Dyspnea, Borg scale                                       6.6±2.2                            −2.5±2.2[\*\*\*](#tfn14-copd-12-1061){ref-type="table-fn"}     6.5±2.7                    −3.6±2.1[\*\*\*](#tfn14-copd-12-1061){ref-type="table-fn"}   0.181
  ${\overset{˙}{V}O}_{2}$, mL⋅min^−1^                       739±213                            −102±46[\*\*\*\*](#tfn15-copd-12-1061){ref-type="table-fn"}    730±208                    −3±44                                                        \<0.0001
  F, breaths⋅min^−1^                                        30.3±5.8                           −2.8±6.8                                                       30.1±4.5                   −3.5±6.2                                                     0.761
  V~T~, mL                                                  1,072±297                          32±172                                                         1,086±322                  155±161[\*\*](#tfn13-copd-12-1061){ref-type="table-fn"}      0.067
  ${\overset{˙}{V}}_{E}$, L⋅min^−1^                         31.4±7.4                           −2.3±2.5[\*\*](#tfn13-copd-12-1061){ref-type="table-fn"}       32.6±11.2                  −0.4±3.4                                                     0.082
  ${\overset{˙}{V}\text{CO}}_{2}$, mL⋅min^−1^               768±260                            −117±73[\*\*\*\*](#tfn15-copd-12-1061){ref-type="table-fn"}    773±273                    3±78                                                         0.0003
  V~D~/V~T~                                                 0.35±0.06                          0.02±0.04                                                      0.35±0.08                  −0.01±0.04                                                   0.108
  ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$           43.4±5.2                           3.5±4.2[\*\*](#tfn13-copd-12-1061){ref-type="table-fn"}        44.8±9.5                   −0.0±4.6                                                     0.047
  ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$   43.0±7.7                           4.0±4.4[\*\*](#tfn13-copd-12-1061){ref-type="table-fn"}        43.0±8.0                   −0.2±4.2                                                     0.017
  ΔFO~2~, %                                                 2.88±0.35                          −0.28±0.25[\*\*\*](#tfn14-copd-12-1061){ref-type="table-fn"}   2.82±0.55                  0.04±0.32                                                    0.006
  T~i~/T~tot~                                               35.3±7.4                           2.5±4.3[\*](#tfn12-copd-12-1061){ref-type="table-fn"}          38.5±5.6                   0.5±4.8                                                      0.246
  HR, beats⋅min^−1^                                         121.1±19.4                         −3.2±18.1                                                      120.3±19.2                 −3.4±13.2                                                    0.973
  ${\overset{˙}{V}O}_{2}$/HR, mL⋅beats^−1^                  6.2±1.7                            −0.7±0.5[\*\*\*\*](#tfn15-copd-12-1061){ref-type="table-fn"}   6.0±1.0                    0.2±0.8                                                      0.0007
  SpO~2~, %                                                 90.2±5.9                           0.5±4.0                                                        90.6±4.7                   0.6±3.5                                                      0.969

**Notes:** Data are presented as mean ± SD. The data of 33 patients were obtained from CPET performed under room air conditions, that is, FiO~2~ =21%. The FiO~2~ of two patients was 24%, and the FiO~2~ of one patient was 30%.

*P*\<0.05,

*P*\< 0.01,

*P*\<0.001,

*P*\<0.001. The post-PR results were compared with the pre-PR results within each group. In the time only increased group, exercise time was increased, but the peak ${\overset{˙}{V}O}_{2}$ was economized after pulmonary rehabilitation; in the two factors increased group, both the exercise time and the peak ${\overset{˙}{V}O}_{2}$, were increased after pulmonary rehabilitation.

**Abbreviations:** ΔFO~2~, the inspired oxygen concentration (FiO~2~) minus expired oxygen concentration (FeO~2~); F, breathing frequency; HR, heart rate; SpO~2~ oxygen saturation; T~i~/T~tot~, the ratio of inspiratory time to total breathing cycle time; ${\overset{˙}{V}\text{CO}}_{2}$, carbon dioxide output; V~D~/V~T~, physiologic dead space/tidal volume ratio; ${\overset{˙}{V}}_{E}$, minute ventilation; ${\overset{˙}{V}O}_{2}$, oxygen uptake; V~T~, tidal volume.

###### 

Correlations between baseline variables and the change ratio of the time--slope at post-PR to the time--slope at pre-PR (n=36)

                                                                           *R*      *P*-value
  ------------------------------------------------------------------------ -------- -----------
  Age, years                                                               0.039    0.823
  BMI, kg⋅m^−2^                                                            0.496    0.002
  Pulmonary function                                                                
   FEV~1~, L                                                               0.032    0.855
  CPET                                                                              
   Dyspnea, at peak ex., Borg scale                                        −0.103   0.551
   Exercise time, at peak ex., sec                                         −0.171   0.320
    ${\overset{˙}{V}O}_{2}$, at peak ex., mL⋅min^−1^                       0.158    0.359
   Time--slope, sec⋅mL^−1^⋅min                                             −0.496   0.002
    ${\overset{˙}{V}\text{CO}}_{2}$, at peak ex., mL⋅min^−1^               0.120    0.488
   F, at peak ex., breaths⋅min                                             0.037    0.829
   V~T~, at peak ex., mL                                                   0.076    0.663
    ${\overset{˙}{V}}_{E}$, at peak ex., L⋅min^−1^                         −0.026   0.880
    ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}O}_{2}$, at peak ex.           −0.348   0.037
    ${\overset{˙}{V}}_{E}$/ ${\overset{˙}{V}\text{CO}}_{2}$, at peak ex.   −0.267   0.117
   V~D~/V~T~, at peak ex.                                                  −0.256   0.132
    ${\overset{˙}{V}O}_{2}$/HR, mL⋅beats^−1^                               0.270    0.111
   pH, at peak ex.                                                         −0.170   0.325
   PaO~2~, at peak ex., mmHg                                               0.224    0.190
   PaCO~2~, at peak ex., mmHg                                              −0.007   0.967
   Plasma lactate, at peak ex., mg⋅dL^−1^                                  0.063    0.721

**Abbreviations:** At peak ex., at peak exercise; BMI, body mass index; CPET, cardiopulmonary exercise testing; F, breathing frequency; FEV~1~, forced expiratory volume in 1 s; HR, heart rate; PaCO~2~, arterial carbon dioxide tension; PaO~2~, arterial oxygen tension; time--slope, exercise time/ $\Delta{\overset{˙}{V}O}_{2}$; VC, vital capacity; ${\overset{˙}{V}\text{CO}}_{2}$, carbon dioxide output; V~D~/V~T~ physiologic dead space/tidal volume ratio; ${\overset{˙}{V}}_{E}$, minute ventilation; ${\overset{˙}{V}O}_{2}$, oxygen uptake; V~T~, tidal volume.
